Plazomicin Is Active Against Metallo-β-Lactamase-Producing Enterobacteriaceae

Plazomicin is an aminoglycoside that was approved in June 2018 by the US Food and Drug Administration for the treatment of complicated urinary tract infections, including pyelonephritis, due to Escherichia coli, Klebsiella pneumoniae, Enterobacter cloacae, and Proteus mirabilis. Plazomicin was engin...

Descripción completa

Detalles Bibliográficos
Autores principales: Serio, Alisa W, Keepers, Tiffany, Krause, Kevin M
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2019
Materias:
Brief Reports
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6446133/
https://www.ncbi.nlm.nih.gov/pubmed/30968059
http://dx.doi.org/10.1093/ofid/ofz123

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6446133/
https://www.ncbi.nlm.nih.gov/pubmed/30968059
http://dx.doi.org/10.1093/ofid/ofz123

Ejemplares similares